Drug interactions
Bevacizumab + Ublituximab
Severity: Minor
Bevacizumab and Ublituximab: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ublituximab depletes B cells and causes sustained immunosuppression, while bevacizumab impairs wound healing and has a limited effect on immune function. Together they could modestly raise infection risk, but a meaningful additive immunosuppressive interaction has not been well established.
What this interaction means in plain words
Bevacizumab and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Bevacizumab belongs to Oncology; Ublituximab belongs to Miscellaneous.
Why it happens
Theoretical additive effects on infection risk; bevacizumab is not a significant immunosuppressant, so the mechanism is not firmly established.
What to do
Monitor for infections and delay elective procedures in patients on bevacizumab because of wound-healing impairment. Screen for hepatitis B before ublituximab as labeled.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bevacizumab and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Bevacizumab
- Bevacizumab + Sunitinib Major
- Bevacizumab + Daunorubicin Moderate
- Bevacizumab + Dengue vaccine Moderate
- Bevacizumab + Doxorubicin Moderate
- Bevacizumab + Doxorubicin liposomal Moderate
- Bevacizumab + Efgartigimod / hyaluronidase sc Moderate
Other interactions of Ublituximab
Frequently asked questions
Can I take Bevacizumab with Ublituximab?
MediHelp rates the interaction as minor. Bevacizumab and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ublituximab depletes B cells and causes sustained immunosuppression, while bevacizumab impairs wound healing and has a limited effect on immune function. Together they could modestly raise infection risk, but a meaningful additive immunosuppressive interaction has not been well established.
How serious is the interaction between Bevacizumab and Ublituximab?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infections and delay elective procedures in patients on bevacizumab because of wound-healing impairment. Screen for hepatitis B before ublituximab as labeled.
What other medicines interact with Bevacizumab?
MediHelp also lists interactions of Bevacizumab with, for example, Sunitinib, Daunorubicin, Dengue vaccine. The full list is on the Bevacizumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
